EUR-Lex & EU Commission AI-Powered Semantic Search Engine
Modern Legal
  • Query in any language with multilingual search
  • Access EUR-Lex and EU Commission case law
  • See relevant paragraphs highlighted instantly
Start free trial

Similar Documents

Explore similar documents to your case.

We Found Similar Cases for You

Sign up for free to view them and see the most relevant paragraphs highlighted.

Case C-136/22 P: Judgment of the Court (Fourth Chamber) of 13 July 2023 — Debrégeas et associés Pharma SAS (D & A Pharma) v European Medicines Agency (EMA) (Appeal — Medicinal products for human use — Regulation (EC) No 726/2004 — Decision by the European Medicines Agency (EMA) not to renew a scientific advisory group — Action for annulment brought by the applicant for a marketing authorisation — Admissibility — Interest in bringing proceedings — Vested and current interest which may arise from another legal action — Conditions)

ECLI:EU:UNKNOWN:62022CA0136

62022CA0136

July 13, 2023
With Google you find a lot.
With us you find everything. Try it now!

I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!

Valentina R., lawyer

11.9.2023

Official Journal of the European Union

C 321/12

(Case C-136/22 P) (<span class="oj-super oj-note-tag">1</span>)

(Appeal - Medicinal products for human use - Regulation (EC) No 726/2004 - Decision by the European Medicines Agency (EMA) not to renew a scientific advisory group - Action for annulment brought by the applicant for a marketing authorisation - Admissibility - Interest in bringing proceedings - Vested and current interest which may arise from another legal action - Conditions)

(2023/C 321/14)

Language of the case: French

Parties

Appellant: Debrégeas et associés Pharma SAS (D & A Pharma) (represented initially by E. Gouesse, D. Krzisch and N. Viguié, avocats, and subsequently by E. Gouesse and N. Viguié, avocats)

Other party to the proceedings: European Medicines Agency (EMA) (represented by: C. Bortoluzzi, S. Drosos, H. Kerr and S. Marino, acting as Agents,)

Operative part of the judgment

The Court:

1.Dismisses the appeal;

2.Orders Debrégeas et associés Pharma SAS (D & A Pharma) to bear its own costs and to pay those of the European Medicines Agency (EMA) relating to the appeal.

Language of the case: French.

(1) OJ C 171, 25.4.2022.

EurLex Case Law

AI-Powered Case Law Search

Query in any language with multilingual search
Access EUR-Lex and EU Commission case law
See relevant paragraphs highlighted instantly

Get Instant Answers to Your Legal Questions

Cancel your subscription anytime, no questions asked.Start 14-Day Free Trial

At Modern Legal, we’re building the world’s best search engine for legal professionals. Access EU and global case law with AI-powered precision, saving you time and delivering relevant insights instantly.

Contact Us

Tivolska cesta 48, 1000 Ljubljana, Slovenia